Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054899
Status:
COMPLETED
Last Update Posted:
2010-03-24
First Post:
2003-02-12
Brief Title:
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
Sponsor:
Epimmune
Organization:
Epimmune
Organization Data
Organization:
Epimmune
Class:
INDUSTRY
Study ID:
EP2101-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Epimmune
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None